Skip to content

Intraperitoneal Ketamine Versus Fentanyl as Adjuvants to Bupivacaine in Laparoscopic Cholecystectomy

Intraperitoneal Instillation of Ketamine Versus Fentanyl as Adjuvants to Bupivacaine for Postoperative Pain Control in Laparoscopic Cholecystectomy _a Double-blinded Randomized Trial.

Status
Not yet recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07670052
Enrollment
84
Registered
2026-06-26
Start date
2026-08-01
Completion date
2027-09-01
Last updated
2026-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Brief summary

Laparoscopic cholecystectomy is the standard surgical treatment for gallbladder stones; however, the origin of pain after LC is multifactorial and complex in nature. Pain arising from incision sites is parietal pain, whereas pain from the gall bladder bed is mainly visceral in nature, and shoulder pain is mainly referred owing to the residual carbon dioxide irritating the diaphragm. Intraperitoneal administration of local anesthetics has been shown to improve postoperative pain control and reduce the need for systemic analgesics. The addition of adjuvant agents such as fentanyl or ketamine may further enhance analgesic efficacy. This randomized double-blind study aims to compare the effectiveness of intraperitoneal ketamine versus fentanyl as adjuvants to bupivacaine in reducing postoperative pain and analgesic requirements following laparoscopic cholecystectomy.

Detailed description

Laparoscopic cholecystectomy (LC) is widely recognized as the gold standard for the treatment of gallbladder stones due to its significant advantages over the conventional open surgical approach. These benefits include faster postoperative recovery, reduced surgical morbidity, shorter hospital stay, and decreased postoperative pain. Despite these advantages, postoperative pain remains a major concern and is considered one of the primary factors affecting patient comfort and delaying discharge following surgery. Abdominal pain is usually most pronounced during the first 24 hours after the procedure, while shoulder pain commonly develops on the second postoperative day as a consequence of diaphragmatic irritation caused by residual carbon dioxide. Because postoperative pain after laparoscopic surgery is multifactorial in origin, a multimodal analgesic approach is widely recommended . Various strategies have been employed to improve pain control, including the use of local anesthetics administered alone or in combination with intraperitoneal opioid analgesics. Intraperitoneal (I.P.) administration of local anesthetics has become a popular and effective technique for postoperative pain management, as it can reduce the need for systemic analgesics and minimize the adverse effects associated with nonsteroidal anti-inflammatory drugs and opioids. This approach was first investigated in gynecological laparoscopic procedures and has since been extensively studied in patients undergoing LC. Several studies have demonstrated that the addition of adjuvants such as fentanyl, a potent synthetic opioid, and ketamine, an N-methyl-D-aspartate receptor antagonist, may enhance and prolong postoperative analgesia. Consequently, intraperitoneal instillation of local anesthetics with adjuvant agents represents a simple, safe, and effective method for improving postoperative pain control following LC.

Interventions

DRUGFentanyl

Fentanyl used as an adjuvant to bupivacaine for intraperitoneal instillation during laparoscopic cholecystectomy, a dose of 1 ug/kg is commonly added to the local anesthetic solution. Bupivacaine: Typically, 0.25% to 0.5% concentration is used for intraperitoneal instillation. A common volume is 20 mL, depending on the clinical protocol.

DRUGKetamine

Ketamine used as an adjuvant to bupivacaine for intraperitoneal instillation during laparoscopic cholecystectomy, a dose of 0.25 mg/kg is commonly added to the local anesthetic solution. Bupivacaine: Typically, 0.25% to 0.5% concentration is used for intraperitoneal instillation. A common volume is 20 mL, depending on the clinical protocol.

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Masking description

An independent anesthesiologist randomly divided the patients into 42 groups of patients each using computer-generated random numbers fentanyl group and ketamine group (Group F and Group K). We discreetly placed the randomization results in envelopes until the end of the study. Both ketamine and fentanyl are colorless liquids, and they were digitally encoded so that the researchers who were responsible for postoperative follow-up and data processing were blinded to the group allocation during the whole study period. All patients were also blinded to the group allocation.

Intervention model description

Instillation technique Intraperitoneal instillation of study drugs will be done by the operating surgeon through laparoscopic ports guided by surgical camera after the removal of the gall bladder, onto the gall bladder fossa, under the diaphragm, on the liver bed and patient position was changed to 15° 20° Trendelenburg position for 10 min. Intraperitoneal Instillation: The mixture of bupivacaine and fentanyl or Ketamine is instilled into the peritoneal cavity after securing hemostasis over the gall bladder bed. Study drug doses: Bupivacaine: Typically, 0.25% to 0.5% concentration is used for intraperitoneal instillation. A common volume is 20 mL, depending on the clinical protocol. Fentanyl group (42 patients): When used as an adjuvant to bupivacaine, a dose of 1 ug/kg is commonly added to the local anaesthetic solution. Ketamine group (42 patients): When used as an adjuvant to bupivacaine, a dose of 0.25 mg/kg is commonly added to the local anesthetic solution.

Eligibility

Sex/Gender
ALL
Age
20 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients of age 20-50 years * Patients of either gender * Patients planned to undergo elective LC. * Patients have I-II of the American Society of Anaesthesiologists (ASA)

Exclusion criteria

* Patient's refusal. * body mass index (BMI) ≥40 kg/m2. * History of hypersensitivity to the drugs being evaluated * Inability to comprehend postoperatively the pain assessment scale/neuropsychiatric disorders. * chronic use of opioids and opioid addiction * Patients with acute cholecystitis or converted to open surgery. * Carcinoma of gall bladder * Pregnant female * Bleeding disorders

Design outcomes

Primary

MeasureTime frameDescription
Time of first analgesic request.24 hoursThe primary outcome of the study is comparison of the post-operative analgesic effect regarding the time to first analgesic request of fentanyl versus Ketamine as adjuvants to bupivacaine in patients undergoing laparoscopic cholecystectomy

Secondary

MeasureTime frameDescription
Total analgesia consumption postoperatively.24 hoursTotal Nalphuine consumption in milligrams, in the first 24 hours postoperatively.
Postoperative Numeric Rating Scale of pain24 hours postoperatively.Postoperative Numeric Rating Scale of pain.( in post-anaesthesia care unit, half hour, 2, 6, 12, 18, 24 hours postoperatively)

Contacts

CONTACTTarek Mo Essa Tohamy
tarekessa970@gmail.com+201027342291
CONTACTEman Ah Ismail, MD
emanismail@aun.edu.eg+20 1060223750
PRINCIPAL_INVESTIGATORTarek Mo Essa Tohamy

Assiut University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 27, 2026